Eden Research (LON:EDEN) Stock Price Down 3.3% – Here’s What Happened

Eden Research plc (LON:EDENGet Free Report)’s stock price fell 3.3% on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company’s 50-day moving average is GBX 3.88 and its 200 day moving average is GBX 3.95. The company has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Activity at Eden Research

In related news, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction on Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). 14.02% of the stock is currently owned by insiders.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

See Also

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.